Viral vector technology for cell type specific gene delivery
Viral vector technology for cell type specific gene delivery
批准号:
10796647
负责人:
Aaron Matthew LeBeau
金额:
$14.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2026-02-28
关键词:
AccelerationAdministrative SupplementAntibodiesCell SeparationCellsCore FacilityDedicationsDependovirusEngineeringFee-for-Service PlansGene DeliveryHereditary DiseaseInvestmentsMalignant NeoplasmsMeasuresMinnesotaResearchRunningSecureTechnologyTimeUniversitiesViral Vectorcell typedesignexperimental studygene therapymembernoveltechnology platformtimelinevirus tropism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This administrative supplement is to purchase a Sony benchtop SH800 cell sorter. Cell sorting is essential for
our approach to rationally engineer Adeno-Associated Virus tropism (see R01GM141152 ”Viral vector technology
for cell type specific gene delivery”). At the University of Minnesota Flow Core facility, cell sorting is only available
as a ‘fee-for-service’ performed by a flow core staff member. With this limitation, we have run into two issues: 1)
Because of heavy utilization of the Flow Core’s two sorters, we have trouble securing enough time to conduct
research outlined in our R01. 2) For many pilot/optimization experiments, the high throughput of the Flow Core’s
sorters is underutilized, and their complexity is actually a hindrance. A benchtop sorter will shorten the time
required for consecutive AAV design/measure/optimize cycles and thus enable an accelerated timeline of
experiment outlined in our R01. Taken together, the need to purchase a cell sorter dedicated to this project is
urgent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral vector technology for cell type specific gene delivery
-
批准号:10365787
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2022
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Viral vector technology for cell type specific gene delivery
-
批准号:10581499
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2022
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10410106
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10653106
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10470959
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10545171
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10321260
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10062931
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10408279
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10470949
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10650786
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10411260
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
海外基金